Abstract 2916: The clonal evolution of glioblastoma
Jennifer B. Goldstein(The University of Texas MD Anderson Cancer Center), Phillip Andrew Futreal(The University of Texas MD Anderson Cancer Center), Ravesanker Ezhilarasan(Post Graduate Institute of Medical Education and Research), Giulio Draetta(The University of Texas MD Anderson Cancer Center), Alessandro Carugo(The University of Texas MD Anderson Cancer Center), Erik P. Sulman(NYU Langone Health), Roeland Verhaak(Broad Institute), Mona Jaffari(The University of Texas MD Anderson Cancer Center), Sahil Seth(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27
|Science|1995|1.8k
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|867
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656